Osteoporosis affects a large portion of the population in the United States. According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), over 52 million people currently have osteoporosis or are at the risk of getting it in the future. With such a high amount of people affected, many treatments have been used on patients suffering from bone loss. However, the current treatments for this disease have been linked with an increased risk of getting infections and certain types of cancers later on. Researchers at Washington University in St. Louis have recently discovered a way to create treatments for osteoporosis that lower the risk of aftereffects.Read More
Science Market Update
Glycans, also known as complex carbohydrates, are essential macromolecules involved in nearly all phsyiological and pathological processes. They cover every living cell in the human body and perform a wide variety of tasks including cellular communication, growth, the spread of many diseases, and are necessary for the organisim's survival. However, there are still many glycans with unknown functions due to a lack of research. With the help of a recently awarded grant from the National Institutes of Health to the University of Georgia Athens, there will soon be more research into the roles of complex carbohydrates.Read More
To many people, antioxidants are simply thought of as a good thing to consume, even if the reason why is not clear. A new study from the University of California, San Diego, shows that an overdose of antioxidants can actually inhibit the healing process.Read More
Nearly 2.5 million Americans are either hospitalized or die from traumatic brain injuries every year, and very rarely do these injuries receive proper treatment. Why? Because there are currently no successful treatments for curing these brain injuries. The Department of Defense has awarded the University of Texas Austin, along with 11 other U.S. institutions, a 5 year award of $17 million to develop successful treatments for these injuries.Read More
Researchers in analytical labs working as part of a Texas Medical Center study have found an innovative solution to stimulating the body’s immune system and thus protecting people against a wide variety of life-threatening diseases.
To get under the skin of a tumor is a very difficult task. If the goal is to invade tumor cells, then classic drugs are simply too large to get through. A bioresearch team at the University of California, Los Angeles is collaborating with a startup company to develop particles small enough for the job.
Science researchers at the University of Southern California are in the process of conducting groundbreaking stem cell research by developing a new transgenic mouse line that allows USC scientists to capture early signs of kidney failure. This “mouse TRAP” uses early techniques developed by researchers at Rockefeller University that involve attaching a fluorescent tag to the ribosomes of a specific cell. Scientists can then determine which genes are ordering proteins to be made by looking at these rhibosomes.
Researchers are continuously looking for innovative solutions for treating pulmonary hypertension, a serious condition for many Americans that continues to worsen over time. Occurring when the pressure in blood vessels between the heart and the lungs is too high, heart failure is common with this condition. In California, it is estimated that between 5.5 and 6.5 cases of pulmonary hypertension were fatal per 100,000 causes of death in 2010, according to an age-standardized chart by the CDC. Although there is no cure for pulmonary hypertension, researchers at UCLA may have a way to improve treatment for the condition.
As some life science professionals may have noticed, scientific research today is trending towards more interdisciplinary projects, with a focus on converging the biosciences, the physical sciences and engineering. Scientific convergence makes great synergy possible: math-focused researchers can help scientists understand complex number sets, and scientists make groundbreaking use of these numbers in medical research that can save lives.
Patients with rare diseases come to the University of California, Irvine as a last resort to meet scientists like Dr. Virginia Kimonis. Dr. Kimonis, who specializes in rare diseases, is able to give these patients hope with her vast expertise on treatment for rare diseases and her history of managing a section of the NIH’s Rare Diseases Clinical Research Network dedicated to Prader-Willi, Rett and Angelman syndromes.